Expert Insights

Jia Ruan, MD, highlights recent advancements in the treatment of patients with T-Cell non-Hodgkin lymphoma, presenting updated information on novel agents and ongoing clinical trials in this space.

Oliver Zivanovic, MD, defends HIPEC as standard of care treatment for patients with ovarian cancer, a topic he presented at the 2022 Great Debates and Updates in Women’s Oncology virtual meeting.

Lyudmila Bazhenova, MD, University of California, San Diego, California, discusses the management and treatment of patients with HER2-mutated non-small cell lung cancer, a topic she presented at the 2022 Great Debates and Updates in Lung...

Julie Heimbach, MD, discusses a benchmark study that investigated outcomes of patients who received neoadjuvant chemoradiotherapy followed by liver transplantation for perihilar cholangiocarcinoma.

Julie Vose, MD, provides insight into the latest approaches to initial therapy for patients with aggressive diffuse large B-cell lymphoma at the 2022 Lymphoma, Leukemia & Myeloma Congress in New York.

Yi-Bin Chen, MD, provides insight into the latest FDA approvals for the treatment of patients with acute and chronic graft-versus-host disease.

Rajiv Agarwal, MD, discusses how to best provide palliative care for patients with gastrointestinal cancers, a topic he presented at the 2022 Great Debates and Updates in Gastrointestinal Malignancies virtual meeting.

Ghassan Abou-Alfa, MD, shares insights about the recent FDA approval of tremelimumab plus durvalumab for patients with unresectable hepatocellular carcinoma and discusses findings from the HIMALAYA trial, which led to the approval.

Lyudmila Bazhenova, MD, discusses targeted therapy for MET-dependent lung cancers, a topic she presented at the 2022 Great Debates & Updates in Lung Cancer meeting in New York.

Kristin Higgins, MD, provides an overview on the current and future treatment of small cell lung cancer, a topic she presented at the 2022 Great Debates and Updates in Lung Cancers meeting in New York.